Pharmaceutical formulations for treating ocular conditions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9504645
APP PUB NO 20160106746A1
SERIAL NO

14887259

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are pharmaceutical formulations for treating ocular conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OYSTER POINT PHARMA INC202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ackermann,, Jr Douglas Michael San Francisco, US 16 231
Loudin, James Houston, US 14 81
Mandell, Kenneth J Arlington, US 25 337

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 29, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00